학술논문

M-M-R®II manufactured using recombinant human albumin (rHA) and M-M-R®II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children
Document Type
Article
Source
In Vaccine 27 April 2015 33(18):2132-2140
Subject
Language
ISSN
0264-410X